Can the success with immunotherapy in metastatic urothelial bladder carcinoma be replicated in the neoadjuvant setting?

被引：3
|
作者：
Aoun, Fouad [1 ,2 ]
Mjaess, Georges [2 ]
Nemr, Elie [2 ]
Albisinni, Simone [3 ]
Roumeguere, Thierry [1 ,3 ]
机构：
[1] Inst Jules Bordet, Dept Urol, Brussels, Belgium
[2] Univ St Joseph, Dept Urol, Hotel Dieu France, Beirut, Lebanon
[3] Univ Libre Bruxelles, Univ Clin Brussels, Erasme Hosp, Dept Urol, Brussels, Belgium
来源：
IMMUNOTHERAPY | 2020年 / 12卷 / 17期
关键词：
circulating tumor cells; immune checkpoint inhibitors; immunotherapy; neoadjuvant; urothelial bladder carcinoma; CIRCULATING TUMOR-CELLS; PERIPHERAL-BLOOD; MANAGEMENT;
D O I：
10.2217/imt-2020-0244
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
[No abstract available]
引用
收藏
页码：1209 / 1212
页数：4
相关论文
共 50 条
  • [21] Immunotherapy for metastatic urothelial carcinoma: putting the brakes on releasing the brake
    Zibelman, Matthew
    Plimack, Elizabeth R.
    IMMUNOTHERAPY, 2018, 10 (06) : 423 - 425
  • [22] Immunotherapy with checkpoint inhibitors in local advanced and metastatic urothelial carcinoma
    Miller, Kurt
    Gschwend, Juergen E.
    Merseburger, Axel
    Retz, Margitta
    Stenzl, Arnulf
    AKTUELLE UROLOGIE, 2018, 49 (02) : 142 - 156
  • [23] Immunotherapy for advanced or metastatic urothelial carcinoma: an abridged Cochrane review
    Maisch, Philipp
    Hwang, Eu Chang
    Kim, Kwangmin
    Narayan, Vikram M.
    Bakker, Caitlin
    Kunath, Frank
    Dahm, Philipp
    BJU INTERNATIONAL, 2024,
  • [24] The dilemma of neoadjuvant and adjuvant therapy in urothelial carcinoma: will immunotherapy solve the problem?
    Nuvola, Giacomo
    Rizzo, Alessandro
    Mollica, Veronica
    Massari, Francesco
    IMMUNOTHERAPY, 2022, 14 (04) : 171 - 174
  • [25] Immunotherapy in metastatic urothelial carcinoma: focus on immune checkpoint inhibition
    Arlene Siefker-Radtke
    Brendan Curti
    Nature Reviews Urology, 2018, 15 : 112 - 124
  • [26] Complete response of bony metastatic bladder urothelial cancer to neoadjuvant chemotherapy and cystectomy
    Joudi, Fadi N.
    Dahmoush, Laila
    Spector, David M.
    Konety, Badrinath R.
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2006, 24 (05) : 403 - 406
  • [27] Micropapillary urothelial carcinoma of the urinary bladder: Early surgery or neoadjuvant chemotherapy?
    Ghoneim, I.
    Stephenson, A.
    Gong, M.
    Campbell, S.
    Fergany, A.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [28] Metastatic Pleural Effusion: An Unusual Presentation of Urothelial Bladder Carcinoma
    Javed, Isma N.
    Abdo, Tony
    Ahmad, Nazir
    Jones, Kellie R.
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2019, 11 (05)
  • [29] Utilization of neoadjuvant chemotherapy in stages II and III urothelial carcinoma of the bladder
    Huang, B.
    Tucker, T.
    Bylund, J. R.
    Rinehart, J. J.
    Rowland, R. G.
    Strup, S. E.
    Crispen, P. L.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (07)
  • [30] GENE EXPRESSION SIGNATURE FOR METASTATIC UROTHELIAL CARCINOMA OF THE URINARY BLADDER
    Jensen, J. B.
    Jensen, K. M.
    Ulhoi, B. P.
    Orntoft, T. F.
    Dyrskjot, L.
    EUROPEAN UROLOGY SUPPLEMENTS, 2009, 8 (04) : 225 - 225
12345